Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials.
about
Statins for influenza and pneumoniaThe benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trialsUsing electronic health records to predict costs and outcomes in stable coronary artery diseaseStatin associated hepatic adverse effects: a retrospective review from a regional hospital in sultanate of omanTime trends in the prescription of statins for the primary prevention of cardiovascular disease in the United Kingdom: a cohort study using The Health Improvement Network primary care dataThe impact of statins on health services utilization and mortality in older adults discharged from hospital with ischemic heart disease: a cohort study.Are statin trials in diabetes representative of real-world diabetes care: a population-based study on statin initiators in FinlandAntidepressant response in major depressive disorder: a meta-regression comparison of randomized controlled trials and observational studies.Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort studyRisk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients.Osteoporosis therapies: evidence from health-care databases and observational population studies.Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis.Comparative effectiveness of rosuvastatin versus simvastatin in primary prevention among new users: a cohort study in the French national health insurance database.Initiation rates of statin therapy for the primary prevention of cardiovascular disease: an assessment of differences between countries of the UK and between regions within England.Cost effectiveness of statins in coronary heart disease.Do Statins Reduce the Health and Health Care Costs of Obesity?The additional value of routine electrocardiograms in cardiovascular risk management of older people.Relationship between Statin Utilization and Socioeconomic Deprivation in Hungary.Impact on mortality following first acute myocardial infarction of distance between home and hospital: cohort study.Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules.Use of principal component analysis in the evaluation of adherence to statin treatment: a method to determine a potential target population for public health intervention.Tackling inequalities: are secondary prevention therapies for reducing post-infarction mortality used without disparities?Statin-induced improvements in vulnerable plaques are attenuated in poorly controlled diabetic patients with coronary atherosclerosis disease: a serial optical coherence tomography analysis.An overview of lipid abnormalities in patients with inflammatory bowel diseaseSecondary prevention of heart disease with statins: findings are unexpected.When to stop?The polypill and cardiovascular disease.Participants in research.Secondary prevention of heart disease with statins: groups were as different as chalk and cheese.Secondary prevention of heart disease with statins: study seems to be about tertiary rather than secondary prevention.Statin-prescribing trends for primary and secondary prevention of cardiovascular disease.Prerequisites for a new health care model for elderly people with multimorbidity: the PRISCUS research consortium
P2860
Q24235104-C94C7541-AA32-44F1-907B-5A50FDD8F8D8Q24646234-4C6B4B22-46E5-4ED4-8480-263DF24A6DD1Q28603610-D183D114-EBC2-420E-B5C6-E9CFB06801D9Q28654581-043D9F4D-168E-4F6C-B616-922388FFFA2FQ31108693-8FAE6C4A-FDA7-4AFA-AFFF-81CC4792B485Q33514949-0DC53490-1193-4ED0-ABB2-F3C798973F9FQ33795544-12507692-DC26-4CCB-9400-6B609B1CE5D7Q33936735-7657D2CC-4B80-4724-9117-0F47264A5E05Q33972105-DD1146B6-F12E-4335-B7A0-0550B1A2017CQ34081514-E3C78E51-2314-40E0-86F4-F4B483B7BBB3Q34242906-D73781FE-BD6B-4D40-9E6B-C61F79BE685EQ34491726-D7B6CDB3-F10B-4192-8160-721F997037BFQ34693650-7C645069-75B3-4F7C-897A-791D12F7AD43Q35179448-1585E60D-52D3-4541-9DA6-8F60BC1B53B1Q35417723-B051CE3B-59B9-40F2-8C88-69A2769A581BQ35812297-8092C293-19D1-48DF-B5A5-663481B526D7Q36132123-8ED79CC0-C473-4956-A6FF-9A70B4032EE7Q36724472-34D69C01-1C80-4E4E-A75B-F9A2536ED7D0Q36930829-96FE7D38-5EBC-40A7-AEA6-D84FC0D7BD62Q36957089-E017B361-461D-4760-ADA0-4E9AD14FB6EDQ37897661-264D20B1-052B-407A-B205-930577E9C197Q38045284-A83CBBB5-79FA-4EB4-A831-590123651AF3Q40596277-BFC7EB0B-61EF-4AEA-B185-EDF9EFC58F92Q42406811-056EE381-0CBA-440C-92F7-EB873ACACC17Q42712064-77CA3049-F061-4EC0-AD9E-7F1E3542A8DFQ42993505-4DAED0A2-083B-4F84-9AB8-511513E6B4C2Q43045345-1B776969-1EFC-46EE-A57B-428BFE40CCC4Q43058666-E2FEE34A-AD67-49A5-BB5E-AA117E8160A0Q43059040-DE1E1EF5-6E31-4E7F-8F0E-AE6D9A8F1644Q43059426-E142E7E3-CC51-4F49-80BB-953DB304BAB9Q47109312-CCFF318A-BBF9-45FE-B943-9B483EE50A9BQ57518642-477824B6-71C7-408B-B7F6-6C1ACDA968AD
P2860
Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Statin use in the secondary pr ...... patients in randomised trials.
@ast
Statin use in the secondary pr ...... patients in randomised trials.
@en
type
label
Statin use in the secondary pr ...... patients in randomised trials.
@ast
Statin use in the secondary pr ...... patients in randomised trials.
@en
prefLabel
Statin use in the secondary pr ...... patients in randomised trials.
@ast
Statin use in the secondary pr ...... patients in randomised trials.
@en
P2093
P2860
P1433
P1476
Statin use in the secondary pr ...... patients in randomised trials.
@en
P2093
Christopher Bartlett
Peter D Davey
Shah Ebrahim
P2860
P356
10.1136/BMJ.38398.408032.8F
P407
P577
2005-03-24T00:00:00Z